News Center

Home page

Peak Report

News reports

Selected Essay on Quality Month of Pharmaceutical Company

Release time:

2022-12-04

drugs

during the national day, a relative in the village came to me with two boxes of metformin hydrochloride englijing tablets, saying that one of his two boxes of drugs was prepared by the hospital and the other was bought at the pharmacy. The drugstore recommended another one because it did not have the kind that the hospital matched, saying that the effect was the same, but he always felt that the effect was not good after taking it back and wanted to ask whether the psychological effect or the drug effect was really different.

For most drug users, the intuitive effect after taking drugs is all the drug quality connotation they can understand. The drug market is full of flowers. There are dozens or even hundreds of manufacturers of the same drug. It is really difficult for consumers to judge which is better. In order to improve the quality of drugs, pharmaceutical manufacturers need to ensure their effectiveness, safety, stability and uniformity to the greatest extent. In addition, through the reasonable control of production costs, the market competitiveness of products should be enhanced to ensure the economy of drug use by consumers. On my first day at the pharmaceutical factory, I was trained on the concept of

drug quality is not tested, but produced " . In my work practice, I have deeply realized that the quality of drugs is not only based on the test results, but also on the test reports. Changes, deviations, complete quality system, qualified production personnel, raw materials provided by qualified suppliers, confirmed production equipment, good environment, and standardized implementation of production operating procedures, each link is an important part of drug quality. Any changes in production, any fluctuations that deviate from established parameters, need to be addressed through risk assessment. There is a long way to go to ensure the quality of drugs and ensure the life, health and safety of the drug user. The peak is making continuous efforts and striving forward ... With the encouragement of innovative drugs at the national policy level and the comprehensive promotion of drug consistency evaluation, drug manufacturers are facing the survival of the fittest, and the phenomenon of good and bad drugs on the market will come to an end. As a member of the drug production process, I will do my best to work with other members of the team to earnestly perform my duties and effectively ensure the safety of each drug. I firmly believe that the upcoming development of the peak brand metformin hydrochloride nglijing tablets will become The first choice for the majority of diabetic patients.

(Ye Ke, Workshop G01

, Xinjinxi Factory Area)

During the quality activity month of Flight Inspection

, the pharmaceutical company carried out a series of colorful activities around quality, such as hanging banners in the factory area, holding knowledge lectures, setting up learning groups, collecting short videos, and answering knowledge.

coincided with the on-site verification of the

CM082

project by the national bureau and provincial bureau inspectors during the quality month activities. After the inspection, the person in charge of quality sighed and said: "Our employees are becoming more and more confident when facing the inspection. " Looking back on the inspections experienced these years, I also feel a lot of emotion. When I first checked, I was afraid that the inspector would point out the defects, always thinking that the fewer defects, the better. This incorrect mentality has led me to always worry about gains and losses when facing inspections, and regard reducing the lack of clauses as my first priority. Be complacent because there are few defective clauses, and upset because there are many defective clauses. In the face of inspection will be anxious, answer the inspector's questions will be nervous, and even afraid to answer questions. After flight inspection and verification, rectification and correction, our quality system is gradually complete. The gradual improvement of the document system also gave me confidence, because every step of the operation and records are based on evidence, and I can answer the inspector's questions in an orderly manner against the internal documents. Slowly, I changed my position from being inspected to being a student, and the inspector was my best teacher. Now, for their own management difficulties, I will take the initiative to consult the teacher, hoping to get some advice from the teacher. The examination teacher will often patiently answer my questions and answer my doubts. Look! The inspector is not so terrible as imagined, but a group of persistent and lovely people.

As the saying goes

gold is not barefoot, no one is perfect " , there is no perfect enterprise in the world, and every enterprise has some defects and deficiencies more or less. As long as we do our job well, do not cheat or cheat, sincerely and humbly listen to the teacher's teachings, frankly accept the defects pointed out by the teacher, understand and actively and thoroughly rectify, our quality management will become more and more comprehensive. However, there is no end to quality management. It still requires generations of quality people to strengthen their beliefs, face quality management with the spirit of craftsmen, and contribute their own strength to achieve a century-old peak. We 've been on the road! ( QC

A Fu Junli)

My post and my quality responsibility

The first sight of this topic aroused my deep thinking. As a workshop manager, facing the production line, how should the quality responsibility of this post be reflected and continued? In fact, the quality responsibility of the post is the responsibility of the whole staff, while I play the role of supervising, executing, summarizing, deepening and training the executor of a circular process.

, as the executor, should fully interpret the contents of the existing documents, sort out the key quality control points of each product, each post and each equipment operation from the documents, and strengthen the memory of the operators in the training, so as to avoid the existing irregularities that have been found and have countermeasures as much as possible in the subsequent production. For example, according to the pipeline design of the preparation system, it is necessary to confirm that the bottom valve of the tank is closed before use after cleaning and sterilization. If it is not closed, the preparation operation should be stopped, and there are regulations in the document and records should be formed to effectively prevent leakage accidents.

Secondly, during the inspection process, with the interpretation of existing documents, communicate effectively with employees, and analyze potential problems in the production operation process such as process and equipment from the perspective of employees, or problems that employees have found but have not formed documents and records. For example, the newly purchased high-speed labeling machine of eye drops production line, after communicating with the operators during the on-site inspection of the production process, found that attention should be paid to whether the labeling position and printing position of the label drift after label replacement. After the ribbon is replaced, check and confirm the printing effect and whether the ribbon position is not correct. When the production process is stopped, the roller products entering the labeling machine need to be empty. There is no description of relevant contents in the troubleshooting of

manufacturer's data. They are all summarized by the workshop according to the actual operation process and confirm whether other labeling machines have the same problems. These precautions are added to the standard operating procedures of labeling machines to prevent the occurrence of such problems. The same applies to other equipment. During operation, attention should be paid to whether changes will be caused by similar replacement of packaging materials, materials or components.

Finally, as managers, they should make an in-depth analysis of the problems found in the inspection, add inspection or operation contents to the corresponding documents and records after summarizing, then carry out timely training, and confirm the implementation and elimination measures in the future inspection. In this way, a cycle of supervision, implementation, summary, deepening and training is formed, and the quality responsibility is continued in the form of documents and records.

The responsibility for quality is endless, and it is always necessary to set the quality policy of the enterprise

" to pursue excellent quality; to be a high-quality medicine for the benefit of human society! "is printed in the mind, keep learning and updating, and be the continuator of quality responsibility! (Preparation Workshop

Fang Ling)

More information

Two Cement Enterprises Prosperous Production and Sales in May

With the gradual easing of the new crown epidemic, all over the project has started, Hubei, Yunnan two provinces cement market continued to improve, Daye peak cement company, Yunnan peak cement company two enterprises have recently shown a good momentum of production and sales. In May, the sales volume of Yunnan Jianfeng cement continued to rise. As of the time of publication, the average daily shipment volume reached more than 7400 tons, and the highest daily shipment volume reached more than 8700 tons, and the production capacity was fully released. Over the past few days, Yunnan Peak Packaging System has made great efforts to overcome the impact of narrow distribution sites and many cement varieties to ensure the completion of delivery tasks with good quality and quantity every day. In order to further balance production and sales and create conditions for the homogenization of cement delivered from the factory, Yunnan peak packaging system puts forward work requirements for relevant posts, emphasizes equipment inspection and process inspection during production, strictly implements safety operation procedures, and maintains safe and efficient operation of the system. Due to the impact of the new crown epidemic, Hubei cement market started late, Wuhan market is the hardest hit area, the current project construction is still not fully started, the volume pressure is greater. For this reason, daye peak departments cooperate closely, increase market development efforts, develop new mixing stations, focus on increasing the bulk share of Xianning, Huanggang and Wuhan markets, seize the opportunity of fine weather, and achieve the goal of rapid output. Internally, on the basis of equipment technical renovation and production capacity improvement, the delivery is effectively guaranteed, and the daily delivery capacity can basically be maintained at 10,000 tons. In May, Daye Peak sold more than 300000 tons of cement, an increase of 20% over the same period last year, with an average daily sales volume of more than 9900 tons, the highest in the current period since Daye Peak was put into production.

2020

07-31

The company's "safe production month" activities are about to start

June 2020 is the 19th national "safe production month", the theme of the activity is "eliminating hidden dangers of accidents and building a strong line of defense". A few days ago, the group company issued a notice to arrange the activities related to the organization of "safe production month" and put forward requirements. According to the group's "safe production month" activity plan, different key thematic activities will be held in the four weeks of June. The first week is the "Publicity and Safety Education Week", which focuses on the use of WeChat groups, electronic screens, publicity boards, banners, slogans and other forms for safety publicity, and organizes the study of national safety regulations, company safety system specifications and accident-free factory creation standards, Organize to watch safety warning education films, learn accident cases, etc., and improve employees' safety awareness by creating a safety atmosphere and organizing learning activities. The focus of the activities in the second week is "looking for potential sources of danger around you". Each unit takes departments and teams as units to investigate and analyze the potential risk factors in the process of daily production, maintenance and operation, find out the hazard sources that have not been included in the scope of risk point control, and report to the safety management department of the unit to form a risk assessment report, put forward solutions or suggestions, and supervise the implementation of rectification and timely eliminate potential safety hazards. The third week is the "on-site safety innovation achievements exhibition week", which focuses on the achievements of each unit in on-site safety management and on-site safety facilities in the past year, which are displayed in the form of pictures and texts through beautiful articles and wechat, so as to learn from each other and promote common progress. The fourth week is the "safety training and drill week", and the group company organizes the standardization of safety production and the elimination of hidden dangers.

2020

07-31

Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua

News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.

2020

07-31

Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua

2020

07-30

Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua

2020

07-22

The 14th meeting of the 10th board of directors and the 9th meeting of the 9th board of supervisors held to review and approve the annual work report and other relevant proposals

On April 24, Jiang Xiaomeng, chairman of the group company, presided over the 14th meeting of the 10th board of directors of the company, and deliberated and passed 14 related reports and motions such as the 2019 annual board of directors report, the 2019 general manager business report and the 2019 annual report. The general manager's report pointed out that 2019 is the first year of the implementation of the group's new five-year strategic development plan (2019-2023) and the new three-year business plan (2019-2021) for each business sector. the management team has carried out various operation and management work in an orderly manner around the general policy of "innovation and reform, integration and promotion, scientific layout and steady development", and has better completed the business objectives set by the board of directors at the beginning of the year. In the whole year, the company achieved a total operating income of 3.548 billion billion yuan, an increase of 5.51 percent over the same period last year; net profit attributable to shareholders was 0.725 billion billion yuan, with earnings per share reaching 2.11 billion yuan, an increase of 23.14 percent over the same period last year, a record high; total assets at the end of the year were 5.475 billion billion yuan, an increase of 11.71 percent over the same period last year; and net assets attributable to shareholders were 3.789 billion billion yuan, an increase of 19.81 percent. During the reporting period, the company's two main businesses have achieved great development, benefiting from the further promotion of supply-side structural reform, the overall operation of the cement industry in 2019 is stable, and the industry benefits are further improved. During the reporting period, the company made new progress in the construction of cement projects, completed the acquisition, capital increase and name change of Guizhou Mingchuan (Guizhou Huangping Jianfeng Cement Co., Ltd.), and continued to invest in the construction of its new dry cement production line with a daily output of 4500 tons of clinker.

2020

07-31

< 1...23 24 25...61 > 跳转到页